Nomura Small Cap Core Fund Class R6 (DCZRX)
| Fund Assets | 5.79B |
| Expense Ratio | 0.68% |
| Min. Investment | $1,000 |
| Turnover | 23.00% |
| Dividend (ttm) | 1.38 |
| Dividend Yield | 4.28% |
| Dividend Growth | 253.72% |
| Payout Frequency | Annual |
| Ex-Dividend Date | n/a |
| Previous Close | 32.12 |
| YTD Return | 5.94% |
| 1-Year Return | 9.18% |
| 5-Year Return | 30.42% |
| 52-Week Low | 23.30 |
| 52-Week High | 32.87 |
| Beta (5Y) | n/a |
| Holdings | 141 |
| Inception Date | May 2, 2016 |
About DCZRX
Macquarie Small Cap Core Fund Class R6 is an actively managed mutual fund focused on U.S. small-cap equities. Its primary objective is long-term capital appreciation by investing chiefly in stocks of small-cap companies that exhibit a blend of attractive valuations, solid growth potential, and strong cash flows. The fund seeks to maintain broad diversification, typically holding over 130 securities, and ensures that at least 80% of its net assets are allocated to companies falling within the market capitalization range of the Russell 2000 Index. The fund’s portfolio reflects a balanced approach between growth and value stocks within the small-cap segment, spanning diverse sectors such as industrials, energy, consumer cyclicals, technology, and healthcare. Managed by a seasoned investment team with significant tenure, the fund utilizes rigorous stock selection and daily risk exposure reviews to identify opportunities in the under-researched U.S. small company market. Macquarie Small Cap Core Fund Class R6 is recognized for its cost efficiency, with a competitive expense ratio, and serves investors seeking diversified exposure to the dynamic U.S. small-cap equity landscape.
Performance
DCZRX had a total return of 9.18% in the past year, including dividends. Since the fund's inception, the average annual return has been 15.05%.
Top 10 Holdings
15.39% of assets| Name | Symbol | Weight |
|---|---|---|
| Semtech Corporation | SMTC | 2.04% |
| Axsome Therapeutics, Inc. | AXSM | 1.68% |
| BridgeBio Pharma, Inc. | BBIO | 1.67% |
| Federal Signal Corporation | FSS | 1.61% |
| Travere Therapeutics, Inc. | TVTX | 1.47% |
| Construction Partners, Inc. | ROAD | 1.43% |
| Ligand Pharmaceuticals Incorporated | LGND | 1.40% |
| Old National Bancorp | ONB | 1.39% |
| Supernus Pharmaceuticals, Inc. | SUPN | 1.38% |
| IMAX Corporation | IMAX | 1.32% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 15, 2025 | $1.38363 | Dec 15, 2025 |
| Dec 16, 2024 | $0.39117 | Dec 17, 2024 |
| Dec 18, 2023 | $1.04052 | Dec 19, 2023 |
| Dec 16, 2022 | $0.999 | Dec 19, 2022 |
| Dec 17, 2021 | $2.024 | Dec 20, 2021 |
| Dec 18, 2020 | $0.266 | Dec 21, 2020 |